Lionel Fajolle

Vice President, Specialty Care Business Unit

Lionel Fajolle is responsible for the Ferring Specialty Care Business Unit, encompassing treatments for both orthopaedics and gastroenterology therapeutic areas.

Lionel has more than 20 years of pharmaceutical industry experience in both U.S. and global markets, across a variety therapeutic areas. He joined Ferring in 2018 as leader of the Orthopaedics and Endocrinology Business Unit. In 2020, he assumed leadership of the Specialty Care Business Unit. Prior to Ferring, Lionel spent 20 years at Sanofi where he progressed through various sales and marketing leadership roles of increasing responsibility.

Lionel holds a PharmD from University Paul Sabatier, Pharmacy School in Toulouse, and a Master of Business Administration from the ESSEC Business School, Paris, France.

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience. ORTIKOS is a trademark of Sun Pharma Global FZE.

©2008-2020 Ferring Pharmaceuticals.  US-CORP-2100028